This protocol addresses aseptic meningitis in the setting of clinical concern for herpes simplex virus (HSV) meningitis or encephalitis. When HSV cannot be excluded, management requires prompt attention to both stabilisation and antiviral coverage.
Initial management prioritises stabilisation of cardiopulmonary status. Intravenous fluid support is addressed within the first 48 hours. An antiviral agent is incorporated into the regimen given the concern for HSV involvement — the full protocol details the specific agent, dosing, and sequencing.
Complete regimen, dosing guidance, and clinical decision pathway available via the structured protocol below.